Overview
Philip Friedlander is an Oncologist in Fort Lee, New Jersey. Dr. Friedlander is rated as an Experienced provider by MediFind in the treatment of Oral Squamous Cell Carcinoma. His top areas of expertise are Melanoma, Merkel Cell Carcinoma, Squamous Cell Skin Carcinoma, Multiple Myeloma, and Thyroidectomy.
His clinical research consists of co-authoring 39 peer reviewed articles and participating in 5 clinical trials. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
1555 Ctr Ave, Suite 2, Fort Lee, NJ 07024
1 Gustave L Levy Pl, New York, NY 10029
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
5 Clinical Trials
New York University
Zujun Li is an Oncologist and a Hematologist in New York, New York. Dr. Li is rated as a Distinguished provider by MediFind in the treatment of Oral Squamous Cell Carcinoma. His top areas of expertise are Glioma, Laryngeal Cancer, Colorectal Cancer, and Throat Cancer.
Northwell Health Center For Advanced Medicine, RJ Zuckerberg Cancer Center
Nagashree Seetharamu, MD, MBBS, is an Associate Professor of Medicine at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. Board certified in Internal Medicine, Hematology, Medical Oncology and Hospice/Palliative medicine, she specializes in cancers of the head and neck and thoracic malignancies (lung cancer, mesothelioma, thymic tumors). She maintains an active clinical practice at the Monter Cancer Center where she focuses on providing compassionate, personalized, evidence-based multidisciplinary care. Dr. Seetharamu has established her reputation at the national level through her active involvement, and leadership within influential oncology organizations that steer the direction of clinical cancer care and research across the United States, and globally. She is a full member of both the Cancer Prevention Committee and Respiratory Committee of Alliance for Clinical Trials in Oncology. This is a national, NCI-sponsored, cooperative group that develops, fund and conducts clinical trials at many academic and community oncology centers across the country. In her position on these committees, she collaborates with clinical research experts across the country to establish standards-of-care, oversees the conduct of existing clinical trials, develops innovative and impactful hypotheses, and formulate future clinical trials. Dr. Seetharamu is the institutional principal investigator on over 10 clinical trials, has co-authored over 50 publications and book chapters and is a sought after speaker at various regional, national and international events related to Head and Neck and Thoracic cancer. Dr. Seetharamu is also Associate Program Director of the Medical Oncology and Hematology Fellowship Program for the Northwell Health Cancer Institute. In this role, she provides hands-on involvement in the recruitment, education and mentorship of future generations of physicians. Dr. Seetharamu trained in internal medicine at Long Island Jewish Medical Center and in hematology/oncology at New York University Medical Center. Dr. Seetharamu is rated as a Distinguished provider by MediFind in the treatment of Oral Squamous Cell Carcinoma. Her top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC), and EGFR Positive Lung Cancer.
Memorial Solid Tumor Group
Loren Michel is an Oncologist in New York, New York. Dr. Michel is rated as a Distinguished provider by MediFind in the treatment of Oral Squamous Cell Carcinoma. His top areas of expertise are Head and Neck Squamous Cell Carcinoma (HNSCC), Polymorphous Low Grade Adenocarcinoma, Epithelial-Myoepithelial Carcinoma, and Glioma. Dr. Michel is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- MelanomaDr. Friedlander isElite. Learn about Melanoma.
- Distinguished
- Merkel Cell CarcinomaDr. Friedlander isDistinguished. Learn about Merkel Cell Carcinoma.
- Advanced
- Basal Cell Skin CancerDr. Friedlander isAdvanced. Learn about Basal Cell Skin Cancer.
- Bone TumorDr. Friedlander isAdvanced. Learn about Bone Tumor.
- Eccrine PorocarcinomaDr. Friedlander isAdvanced. Learn about Eccrine Porocarcinoma.
- Head and Neck Squamous Cell Carcinoma (HNSCC)
- Multiple MyelomaDr. Friedlander isAdvanced. Learn about Multiple Myeloma.
- Olfactory NeuroblastomaDr. Friedlander isAdvanced. Learn about Olfactory Neuroblastoma.
- Experienced
- Acinic Cell Carcinoma of Salivary GlandsDr. Friedlander isExperienced. Learn about Acinic Cell Carcinoma of Salivary Glands.
- Adenoid Cystic CarcinomaDr. Friedlander isExperienced. Learn about Adenoid Cystic Carcinoma.
- AgranulocytosisDr. Friedlander isExperienced. Learn about Agranulocytosis.
- ALK-Positive Non-Small Cell Lung CancerDr. Friedlander isExperienced. Learn about ALK-Positive Non-Small Cell Lung Cancer.
- Ampullary CancerDr. Friedlander isExperienced. Learn about Ampullary Cancer.
- Anal CancerDr. Friedlander isExperienced. Learn about Anal Cancer.
